| 241 |
Monitoring antiviral active metabolite (N-hydroxycytidine) levels in plasma in presence of carboxylesterase-2 inhibitor verapamil using copper tetracyanoquinodimethane enhanced sensor |
Department of Pharmaceutical Analytical Chemistry |
2023 |
| 242 |
Nanotechnology as a promising approach to combat multidrug resistant bacteria: A comprehensive review and future perspectives |
|
2023 |
| 243 |
Nanotechnology-Based Strategies to Combat Multidrug-Resistant Candida auris Infections |
|
2023 |
| 244 |
Naturally occurring phenylethanoids and phenylpropanoids: antimalarial potential |
Department of Pharmacognosy |
2023 |
| 245 |
New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity |
Department of Pharmaceutical Organic Chemistry |
2023 |
| 246 |
New nitazoxanide derivatives: design, synthesis, biological evaluation, and molecular docking studies as antibacterial and antimycobacterial agents |
Department of Pharmaceutical Organic Chemistry |
2023 |
| 247 |
NiFe‑based Prussian blue analogue nanopolygons hybridized with functionalized glyoxal polymer as a voltammetric platform for the determination of amisulpride in biological samples |
Department of Pharmaceutical Analytical Chemistry |
2023 |
| 248 |
Non-coding RNA-directed therapeutics in lung cancer: Delivery technologies and clinical applications |
Department of Industrial Pharmacy |
2023 |
| 249 |
Novel Drugs Obtained via Biotransformation—In Memory of the Late Scientists Frieder Schauer and Peter Grunwald |
|
2023 |
| 250 |
Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: Design, synthesis, and biological evaluation |
Department of Pharmaceutical Organic Chemistry |
2023 |